Kymera Therapeutics has now reported top-line data from its BroADen Phase 1b trial of KT-621, a once-daily oral STAT6 degrader, in patients with moderate to severe atopic dermatitis, alongside ...

Students will face more competency-based questions, including case studies, data interpretation, source-based items, and ...

Deep-brain recordings showed that Mounjaro and Zepbound briefly shut down the craving circuits linked to food noise in a ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

A useful guide to the best learning options available to you at that moment is a compilation of the most effective data ...

A new analysis linking clinical and census data finds individual factors, rather than neighborhood conditions, are more strongly associated with glaucoma risk and severity. The study underscores the ...

The media widely reported on a study finding that the world would be $38 trillion poorer in the future unless action was ...

When the federal vaccine committee hand-picked by anti-vaccine Health Secretary Robert F. Kennedy Jr. meets again this week, ...

From “experimental archaeology” to the mysterious appeal of exploration, the wide-ranging subjects detailed in these titles captivated Smithsonian magazine’s science contributors this year ...

Democrats pressed the NASA nominee on his leaked plans for the agency and the unusual circumstances of his nomination.

Many people trust chatbots without thinking twice. Here’s a grounded look at why that trust can fail and what’s worth ...